|Podcasts|August 11, 2021

Pap Talk S3 E12: Legally Speaking: Methotrexate in an intrauterine pregnancy

Author(s)Lindsey Carr, Editor, James M. Shwayder, MD, JD

Hear from James Shwayder, MD, as he goes through the details of a case involving methotrexate in an intrauterine pregnancy that eventually led to fetal demise.

The article originally appeared in the May issue of Contemporary OB/GYN®. For ultrasound images and a visual roundup of the case, watch the interview here.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Documentation saves the day

ByHindi Stohl, MD, JD,James M. Shwayder, MD, JD

September 20th 2023

Is this a missed diagnosis of abnormal uterine bleeding?

ByHindi Stohl, MD, JD,James M. Shwayder, MD, JD

May 18th 2023

Was this fourth-degree laceration properly repaired?

ByAndrew I. Kaplan, Esq

March 15th 2023

Is this a case of negligence?

ByHindi Stohl, MD, JD,James M. Shwayder, MD, JD

January 16th 2023

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

ByLindsey Carr, Editor

December 22nd 2022

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Pap Talk S3 E12: Legally Speaking: Methotrexate in an intrauterine pregnancy

Newsletter

Related Content

Documentation saves the day

Is this a missed diagnosis of abnormal uterine bleeding?

Was this fourth-degree laceration properly repaired?

Is this a case of negligence?

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

DARE to PLAY sildenafil cream becomes commercially available for women in select states

High costs and transfusions linked to acute heavy menstrual bleeding

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more